Takayuki Sakai - My portal

Profile Information

Development of antitumor biguanides targeting energy metabolism and stress responses in the tumor microenvironment.

Takayuki Sakai, Yoshiyuki Matsuo, Kensuke Okuda, Kiichi Hirota, Mieko Tsuji, Tasuku Hirayama, Hideko Nagasawa

Scientific reports, 11(1) 4852-4852, Mar 1, 2021
Effects of 2-(2-Chlorophenyl)ethylbiguanide on ERAD Component Expression in HT-29 Cells Under a Serum- and Glucose-Deprived Condition.

Kentaro Oh-Hashi, Shiori Matsumoto, Takayuki Sakai, Yoko Hirata, Kensuke Okuda, Hideko Nagasawa

Applied biochemistry and biotechnology, 188(4) 1009-1021, Aug, 2019 Peer-reviewed
Elucidating the rapid action of 2-(2-chlorophenyl)ethylbiguanide on HT-29 cells under a serum- and glucose-deprived condition.

Kentaro Oh-Hashi, Shiori Matsumoto, Takayuki Sakai, Yuki Nomura, Kensuke Okuda, Hideko Nagasawa, Yoko Hirata

Cell biology and toxicology, 34(4) 279-290, Aug, 2018 Peer-reviewed
Elucidation of a novel phenformin derivative on glucose-deprived stress responses in HT-29 cells.

Kentaro Oh-Hashi, Nao Irie, Takayuki Sakai, Kensuke Okuda, Hideko Nagasawa, Yoko Hirata, Kazutoshi Kiuchi

Molecular and cellular biochemistry, 419(1-2) 29-40, Aug, 2016 Peer-reviewed